Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Monte Rosa Therapeutics (GLUE)
NASDAQ:GLUE
RESEARCH TOOLSreports
Holding GLUE?
Track your performance easily
Monte Rosa Therapeutics (GLUE) Ownership Overview
21.76% Insiders
20.78% Mutual Funds
39.96% Other Institutional Investors
7.74% ETFs
9.75% Public Companies and
Individual Investors
The ownership structure of Monte Rosa Therapeutics (GLUE) stock is a mix of institutional, retail, and individual investors. Approximately 68.49% of the company’s stock is owned by Institutional Investors, 21.76% is owned by Insiders, and 9.75% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Oct 30, 2024 | Versant Venture Capital Vi, L.p. >10% Owner | xxxxxxxxxxxxx | $1489973 |
| Sep 24, 2024 | Versant Venture Capital Vi, L.p. >10% Owner | xxxxxxxxxxxxx | $7384330 |
| Sep 13, 2024 | Versant Venture Capital Vi, L.p. >10% Owner | xxxxxxxxxxxxx | $3404761 |
| Jul 09, 2024 | Dunn Edmund Cao | xxxxxxxxxxxxx | $6166 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $176060 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,692,298 | Insider | 12.52% | 53,307,625 | |
| 5,652,922 | Insider | 9.20% | 39,174,749 | |
| 4,916,095 | Institution | 8.00% | 34,068,538 | |
| 3,406,223 | Institution | 5.54% | 23,605,125 | |
| 2,404,194 | Institution | 3.91% | 16,661,064 | |
| 2,069,100 | Institution | 3.37% | 14,338,863 | |
| 1,754,462 | Institution | 2.86% | 12,158,422 | |
| 1,472,331 | Institution | 2.40% | 10,203,254 | |
| 1,336,920 | Institution | 2.18% | 9,264,856 | |
| 982,758 | Institution | 1.60% | 6,810,513 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,406,223 | Institution | 5.54% | 23,605,125 | |
| 2,069,100 | Institution | 3.37% | 14,338,863 | |
| 1,336,920 | Institution | 2.18% | 9,264,856 | |
| 982,758 | Institution | 1.60% | 6,810,513 | |
| 952,900 | Institution | 1.55% | 6,603,597 | |
| 923,019 | Institution | 1.50% | 6,396,522 | |
| 852,355 | Institution | 1.39% | 5,906,820 | |
| 536,436 | Institution | 0.87% | 3,717,501 | |
| 416,599 | Institution | 0.68% | 2,887,031 | |
| 365,906 | Institution | 0.60% | 2,535,729 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,350,106 | Institution | 2.20% | 11,475,901 | |
| 1,179,662 | Institution | 1.92% | 8,175,058 | |
| 683,679 | Institution | 1.11% | 5,811,272 | |
| 398,751 | Institution | 0.65% | 2,763,344 | |
| 186,976 | Institution | 0.30% | 1,589,296 | |
| 210,161 | Institution | 0.34% | 1,368,148 | |
| 152,530 | Institution | 0.25% | 1,296,505 | |
| 96,831 | Institution | 0.16% | 671,039 | |
| 76,962 | Institution | 0.13% | 533,347 | |
| 60,631 | Institution | 0.10% | 515,364 |
FAQ
Who Owns Monte Rosa Therapeutics (GLUE)?
According to the latest TipRanks data, approximately 39.96% of the company's stock is held by institutional investors, 21.76% is held by insiders, and 9.75% is held by retail investors.
What percentage of Monte Rosa Therapeutics (GLUE) stock is held by institutional investors?
According to the latest TipRanks data, approximately 39.96% of Monte Rosa Therapeutics (GLUE) stock is held by institutional investors.
What percentage of Monte Rosa Therapeutics (GLUE) stock is held by retail investors?
According to the latest TipRanks data, approximately 9.75% of Monte Rosa Therapeutics (GLUE) stock is held by retail investors.
Who owns the most shares of Monte Rosa Therapeutics (GLUE)?
Ali Behbahani owns the most shares of Monte Rosa Therapeutics (GLUE).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.